(855) 755-4754

Call today For A Consultation

Facebook Twitter
  • Dangerous Drugs
    • Zantac Cancer
    • Metformin
    • Abilify
    • Taxotere
    • Onglyza/Kombiglyze
    • Zofran
    • Xarelto
    • Invokana
    • SSRI Birth Defects
    • Pseudotumor Cerebri
    • GranuFlo/NaturaLyte
    • Clomid
    • Actos
    • Yaz/Yasmin
    • Elmiron Vision Loss Lawsuits
  • Dangerous Devices
    • 3M Defective Earplug Lawsuits
    • Essure
    • Transvaginal mesh
    • Knee Replacement
    • Hernia Mesh
    • IVC Filter
  • Dangerous Products
    • Allergen Breast Implants
    • Talcum Powder Cancer Lawsuits
    • Juul E-Cigarette
    • Round Up
  • Cases
    • Employee Retention Credit
    • Camp Lejeune Water Contamination
    • Opioids
    • Nursing Home Neglect
    • Automaker
    • GM Recall
    • NFL Head Injury
  • Blog
  • Contact

Verticals

  • Clomid

    Recent scientific studies reveal that women who use Clomid during pregnancy face a higher risk of having a child with serious birth defects, some potentially fatal.

  • Pseudotumor cerebri

    Our attorneys here at Principal Law Group are currently investigating possible law suits on behalf of women who have used specific kinds of birth control and are now suffering from pseudotumor cerebri.

  • Invokana

    The problem with Invokana is that it can dehydrate some patients, decrease blood volume, and cause poor circulation in the body.

  • Xarelto

    Xarelto has no known antidote, meaning that it can be impossible for doctors to stop severe hemorrhaging in patients taking Xarelto.

  • Zofran

    Zofran is used alone or with other medications to prevent and treat nausea and vomiting associated with post-surgery medications or from chemotherapy and radiation therapy.

  • Onglyza/Kombiglyze

    Both Onglyza and Kombiglyze, were required to add warnings about the risk of heart failure. Additional, there are warnings about pancreatitis and pancreatic cancer

  • Taxotere

    Taxotere or Doexta is the most prescribed anti-cancer chemotherapy drug on the market due to its ability to interfere with the growth and spread of cancer cells in the body.

  • Abilify

    Even with the growing concerns over stroke risk, Abilify was marketed as a safe and effective for these disorders.

  • Actos

    The popular diabetes drug Actos (pioglitazone hydrochloride) has been linked to an increase in the risk of bladder cancer in some patients.

  • GranuFlo / NaturaLyte

    Patients who received treatment with GranuFlo and NaturaLyte have reported potentially fatal side effects such as heart attack or stroke.

  • Asbestos / Mesothelioma

    When asbestos is broken down, the fibers become airborne and can be easily inhaled and lodged in the lining of the lungs.

  • SSRI Birth Defects

    Selective serotonin reuptake inhibitors - a class of medications used to treat depression - include some popular antidepressants prescribed by healthcare professionals today.

  • Transvaginal Mesh

    Transvaginal mesh is a type of surgical mesh inserted through the vagina, commonly used to treat two conditions suffered by many women.

  • Yaz/Yasmin

    Yaz and Yasmin, a popular birth control pill that has been on the market since 2006, has been linked with a number of serious and often life-threatening complications...

(855) 755-4754

Call today For A Consultation

Blog

Principal Law Group » Blog

For Bayer, a Roundup Deal Would Be Billions Well Spent

Posted on August 9, 2019 by plgadmin

Bayer AG shareholders are daring to imagine a future free of the litigation that has dogged the pharma group’s Roundup weedkiller. It’s an increasingly plausible scenario, and one investors are itching to price in. Evidence is mounting that the German...

Continue Reading →

Maryland Attorney General Brian Frosh Files Charges Against Opioid Manufacturer Purdue Pharma, Related Entities

Posted on May 31, 2019 by plgadmin

BALTIMORE (WJZ) — Maryland Attorney General Brian Frosh announced Wednesday that his office has filed charges against opioid manufacturers Purdue Pharma, L.P., Rhodes Pharmaceuticals and related entities. The charges allege that the companies engaged in a scheme to market prescription opioids...

Continue Reading →

Pradaxa – Conn. Bellwether Trial Verdict: Plaintiff Awarded $542K

Posted on May 24, 2019 by plgadmin

On Friday, May 17, a Connecticut jury awarded $542K over the alleged bleeding risk caused by blood thinner Pradaxa. According to the trial, the lawsuit was filed in May 2016 alleging that the plaintiff, Gino Roberto, had a 40-year history of...

Continue Reading →

Unprecedented Lawsuit Could End Water Fluoridation in US Based on Neurotoxicity Studies

Posted on May 24, 2019 by plgadmin

On November 22, 2016, a coalition including FAN, Food & Water Watch, Organic Consumers Association, American Academy of Environmental Medicine, International Academy of Oral Medicine and Toxicology, Moms Against Fluoridation and several individual mothers, filed a petition calling on the...

Continue Reading →

In Latest Roundup Herbicide Defeat for Bayer, Jury Awards California Couple $2 Billion

Posted on May 13, 2019 by plgadmin

BILLION WITH A B! A jury in Oakland, California, has awarded a couple $2 billion in punitive damages after concluding that sustained exposure to Monsanto Co.’s popular Roundup weed killer led to their cancer diagnoses. The couple will receive an...

Continue Reading →
  • Page 5 of 16
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 16

Contact Info

Principal Law Group
20 F Street NW, 7th Floor
Washington, DC, 20001
855-755-4PLG

Privacy Policy / DNC Policy

Quick Links

  • Home
  • Dangerous Drugs
  • FAQs
  • Blog
  • Contact Us
  • Site Map
Disclaimer - Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer. Attorney sponsoring this site is licensed in Washington DC - Principal Law Group, LLP - 20 F Street NW, 7th Floor, Washington, DC, 20001

Copyright © 2025 Principal Law Group, LLP.